1. Home
  2. NTCL vs FDMT Comparison

NTCL vs FDMT Comparison

Compare NTCL & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCL
  • FDMT
  • Stock Information
  • Founded
  • NTCL 2003
  • FDMT 2013
  • Country
  • NTCL China
  • FDMT United States
  • Employees
  • NTCL N/A
  • FDMT N/A
  • Industry
  • NTCL
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCL
  • FDMT Health Care
  • Exchange
  • NTCL NYSE
  • FDMT Nasdaq
  • Market Cap
  • NTCL 193.8M
  • FDMT 192.2M
  • IPO Year
  • NTCL 2024
  • FDMT 2020
  • Fundamental
  • Price
  • NTCL $1.39
  • FDMT $4.32
  • Analyst Decision
  • NTCL
  • FDMT Buy
  • Analyst Count
  • NTCL 0
  • FDMT 10
  • Target Price
  • NTCL N/A
  • FDMT $32.33
  • AVG Volume (30 Days)
  • NTCL 749.2K
  • FDMT 418.9K
  • Earning Date
  • NTCL 01-01-0001
  • FDMT 08-07-2025
  • Dividend Yield
  • NTCL N/A
  • FDMT N/A
  • EPS Growth
  • NTCL N/A
  • FDMT N/A
  • EPS
  • NTCL N/A
  • FDMT N/A
  • Revenue
  • NTCL $10,101,647.00
  • FDMT $23,000.00
  • Revenue This Year
  • NTCL N/A
  • FDMT $13,048.65
  • Revenue Next Year
  • NTCL N/A
  • FDMT N/A
  • P/E Ratio
  • NTCL N/A
  • FDMT N/A
  • Revenue Growth
  • NTCL N/A
  • FDMT N/A
  • 52 Week Low
  • NTCL $1.09
  • FDMT $2.24
  • 52 Week High
  • NTCL $51.80
  • FDMT $28.93
  • Technical
  • Relative Strength Index (RSI)
  • NTCL N/A
  • FDMT 57.43
  • Support Level
  • NTCL N/A
  • FDMT $3.86
  • Resistance Level
  • NTCL N/A
  • FDMT $4.48
  • Average True Range (ATR)
  • NTCL 0.00
  • FDMT 0.28
  • MACD
  • NTCL 0.00
  • FDMT 0.01
  • Stochastic Oscillator
  • NTCL 0.00
  • FDMT 89.81

About NTCL NETCLASS TECHNOLOGY INC

Netclass Technology Inc is a business-to-business smart education specialist, providing IT solutions to schools, training institutions, corporations, public agencies and other institutions or corporate customers. It offers SaaS subscription service and application development. The solution's modules include teaching management, campus management, online teaching, online examination, epidemic prevention and control, education credit blockchain system, and lecturer evaluation services.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: